Biolinerx ltd. (BLRX)
Income statement / Quarterly
Jun'18Jun'17
RESEARCH AND DEVELOPMENT EXPENSES

4,484

4,062

SALES AND MARKETING EXPENSES

360

288

GENERAL AND ADMINISTRATIVE EXPENSES

883

844

OPERATING LOSS

-5,727

-5,194

NON-OPERATING INCOME (EXPENSES), NET

663

-4

FINANCIAL INCOME

287

304

FINANCIAL EXPENSES

11

3

NET LOSS AND COMPREHENSIVE LOSS

-4,788

-4,897

LOSS PER ORDINARY SHARE - BASIC AND DILUTED

-0.05

-0.05

WEIGHTED AVERAGE NUMBER OF SHARES USED IN CALCULATION OF LOSS PER ORDINARY SHARE

106,630

94,487